Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

By P. Fitzgibbons, David L. Page, Donald L. Weaver, Ann D. Thor, D. Allred, Gary M. Clark, S. G. Ruby, F. O’Malley, J. F. Simpson, James L. Connolly and 4 more. Archives of Pathology & Laboratory Medicine, 2000

1,095 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/a199d6b36bf82534510886d288a70e38567b9095

Citations in the corpus

• Stromal gene expression predicts clinical outcome in breast cancer (2008, unknown): “The hazard ratio for the SDPP poor-outcome group is greater than, and independent of, the hazard ratio for lymph node involvement, the single most clinically accepted factor currently used to predict breast cancer outcom”
• Breast Cancer Histopathology Image Analysis: A Review (2014, unknown): “ation [8], [9], [16].”
• Breast cancer prognostic classification in the molecular era: the role of histological grade (2010, unknown): “Histological grade: contentious issues Despite the utility of histological grade as a prognostic factor for ER-positive disease, there are numerous issues that ought to be considered for the correct use of histological grade in the management of patients with breast cancer [ 36-39 ].”